Literature DB >> 667355

Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin disease.

G P Schechter, F Soehnlen.   

Abstract

Mononuclear leukocytes isloated from the blood of previously treated patients with advanced active Hodgkin disease contained high concentrations of monocytes and showed poor lymphocyte blastogenesis to mitogens. In five of eight patients with disseminated disease, blastogenesis became normal or improved markedly when the leukocyte suspensions were depleted of monocytes before culture. Addition of autologous macrophages to the monocyte-depleted lymphocytes resulted in a reappearance of the inhibition of blastogenesis. Monocyte inhibition was associated with the presence of active disease, lymphocytopenia, and low lymphocyte/monocyte ratios in the peripheral blood. The role of previous treatment is uncertain, since inhibition tended to disappear when the patients were retreated. Inhibitory monocyte-lymphocyte interactions may be one of the causes of impaired cell-mediated immunity in Hodgkin disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667355

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Immune defects in chronic renal impairment: evidence for defective regulation of lymphocyte response by macrophages from patients with chronic renal impairment on haemodialysis.

Authors:  N D Tsakolos; T C Theoharides; E D Hendler; J Goffinet; J M Dwyer; R L Whisler; P W Askenase
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

2.  Immunogenetic studies in retinoblastoma.

Authors:  D F Roberts; M Duggan-Keen; G E Aherne; D R Long
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

Review 3.  Hodgkin's disease and anergy.

Authors:  T A Shiftan; J Mendelsohn
Journal:  Blut       Date:  1979-01-22

4.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Monocyte-dependent serum suppression of lymphocyte blastogenesis in Hodgkin's disease: an association with nephrotic syndrome.

Authors:  J P Crowley; H J Ree; A Esparza
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

6.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

7.  The effect of human monocytes and macrophages on lymphocyte proliferation.

Authors:  J H Passwell; M Levanon; J Davidsohn; F Kohen; B Ramot
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

8.  Depressed T lymphocyte function in brain tumor patients: monocytes as suppressor cells.

Authors:  G W Wood; R A Morantz
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

9.  [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].

Authors:  H W Pees; G Girmann; J Schwamborn
Journal:  Blut       Date:  1980-04

10.  Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.

Authors:  R D Deshazo; C Ewel; S Londono; Z Metzger; J T Hoffeld; J J Oppenheim
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.